D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro

Neuroscience

Volumn 89, Issue 1, 1999, Pages 221-233

  Wong, A C ^a,b   Shetreat, M E ^a,b   Clarke, J O ^a,b   Rayport, S ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Cell culture; Fluorescent ligands; Mesolimbic; Nigrostriatal; Receptor co localization; Synaptic terminals

Indexed keywords

3 (4 AMINOPHENETHYL)SPIPERONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; FLUORESCENT DYE; FM 143; RHODAMINE; TRACER; UNCLASSIFIED DRUG; DOPAMINE RECEPTOR BLOCKING AGENT; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CORPUS STRIATUM; GABAERGIC SYSTEM; IN VITRO STUDY; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SYNAPTOGENESIS; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA; SYNAPTOSOME;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; NEURONS; NUCLEUS ACCUMBENS; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; RHODAMINES; RNA, MESSENGER; SUBSTANTIA NIGRA;

EID: 0033084230     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00284-X     Document Type: Article

References (51)

1. Ariano M. A., Kang H. C., Haugland R. P. and Sibley D. R. (1991) Multiple fluorescent ligands for dopamine receptors. II. Visualization in neural tissues. Brain Res. 547, 208-222.
2. Ariano M. A., Stromski C. J., Smyk-Randall E. M. and Sibley D. R. (1992) D2 dopamine receptor localization on striatonigral neurons. Neurosci. Lett. 144, 215-220.
3. Barone P., Tucci I., Parashos S. A. and Chase T. N. (1987) D-1 dopamine receptor changes after striatal quinolinic acid lesion. Eur. J. Pharmac. 138, 141-145.
4. Barton A. C., Kang H. C., Rinaudo M. S., Monsma F. J., Stewart-Fram R. M., Macinko J. A., Haugland R. P., Ariano M. A. and Sibley D. R. (1991) Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity. Brain Res. 547, 199-207.
5. Betz W. J., Mao F. and Smith C. B. (1996) Imaging exocytosis and endocytosis. Curr. Opin. Neurobiol. 6, 365-371.
6. Caillé I., Dumartin B. and Bloch B. (1996) Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation. Brain Rex. 730, 17-31.
7. Cameron D. L. and Williams J. T. (1993) Dopamine D1 receptors facilitate transmitter release. Nature 366, 344-347.
8. 3H]GABA. Neuroscience 22, 425-439.
9. Dannies P. S., Rudnick M. S., Fishkes H. and Rudnick G. (1984) Spiperone: Evidence for uptake into secretory granules. Proc. Natn. Acad. Sci. U.S.A. 81, 1867-1870.
10. Delle Donne K. T., Sesack S. R. and Pickel V. M. (1997) Ultrastructural immunocytochemical localization of the dopamine D2 receptor within gabaergic neurons of the rat striatum. Brain Res. 746, 239-255.
11. Descarries L., Watkins K. C., Garcia S., Bosler O. and Doucet G. (1996) Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: A quantitative autoradiographic and immunocytochemical analysis. J. Comp. Neurol. 375, 167-186.
12. Dewar K. M., Paquet M. and Reader T. A. (1997) Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation. Neurochem. Int. 30, 613-621.
13. A currents in rat neostriatum medium spiny neurons. Soc. Neurosci. Abstr. 23, 746.
14. A/benzodiazepine receptors in acutely isolated hippocampal astrocytes. J. Neurosci. 15, 2720-2732.
15. Garris P. A., Ciolkowski E. L., Pastore P. and Wightman R. M. (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14, 6084-6093.
16. Gelbard H. A., Teicher M. H., Baidessarini R. J., Gallitano A., Marsh E. R., Zorc J. and Faedda G. (1990) Dopamine D1 receptor development depends on endogenous dopamine. Devl Bruin Res. 56, 137-140.
17. Geldwert D. and Rayport S. (1996) Dopaminergic modulation of nucleus accumbens GABA synapses. Soc. Neurosci. Abstr. 22, 506.
18. Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J. and Sibley D. R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432.
19. Gerfen C. R., Keefe K. A. and Gauda E. B. (1995) D1 and D2 dopamine receptor function in the striatum: Coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15, 8167-8176.
20. Harrison M. B., Wiley R. G. and Wooten G. F. (1990) Selective localization of striatal D1 receptors to striatonigral neurons. Brain Res. 528, 317-322.
21. Harsing L. G. Jr and Zigmond M. J. (1997) Influence of dopamine on GABA release in striatum: Evidence for D1-D2 interactions and non-synaptic influences. Neuroscience 77, 419-429.
22. Harvey J. and Lacey M. G. (1997) A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J. Neurosci. 17, 5271-5280.
23. Hersch S. M., Ciliax B. J., Gutekunst C. A., Rees H. D., Heilman C. J., Yung K. K. L., Bolam J. P., Ince E., Yi H. and Levey A. I. (1995) Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15, 5222-5237.
24. Jung A. B. and Bennett J. P. Jr (1996) Development of striatal dopaminergic function. 1. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors. Devl Brain Res. 94, 109-120.
25. Krantis A., Nichols K., De Blas A. and Staines W. (1994) Demonstration of benzodiazepine receptors in submucosal neurons of the gastrointestinal tract. Neurosci. Lett. 176, 32-36.
26. Le Moine C. and Bloch B. (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRna probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355, 418-426.
27. Le Moine C., Normand E. and Bloch B. (1991) Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. Natn. Acad. Sci. U.S.A. 88, 4205-4209.
28. Lester J., Fink S., Aronin N. and Di Figlia M. (1993) Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons. Brain Res. 621, 106-110.
29. Lu X. Y., Churchill L. and Kalivas P. W. (1997) Expression of D1 receptor mRna in projections from the forebrain to the ventral tegmental area. Synapse 25, 205-214.
30. Maloteaux J. M., Gossuin A., Waterkeyn C. and Laduron P. M. (1983) Trapping of labelled ligands in intact cells: A pitfall in binding studies. Biochem. Pharmac. 32, 2543-2548.
31. Marshall J. F., Ruskin D. N. and LaHoste G. J. (1997) D1/D2 dopamine receptor interactions in basal ganglia functions. In The Dopamine Receptors (eds Neve K. A. and Neve R. L.), pp. 193-219. Humana, Ottawa.
32. Meador-Woodruff J. H., Mansour A., Healy D. J., Kuehn R., Zhou Q.-Y., Bunzow J. R., Akil H., Civelli O. and Watson S. J. (1991) Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 5, 231-242.
33. Moriyama Y., Tsai H. L. and Futai M. (1993) Energy-dependent accumulation of neuron blockers causes selective inhibition of neurotransmitter uptake by brain synaptic vesicles. Archs Biochem. Biophys. 305, 278-281.
34. Nicola S. M. and Malenka R. C. (1997) Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens. J. Neurosci. 17, 5697-5710.
35. A receptors on cerebellar granule cells as determined by a quantitative immunogold method. J. Neurosci. 15, 2948-2960.
36. Parsons L. H. and Justice J. B. Jr (1992) Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis. J. Neurochem. 58, 212-218.
37. Pennartz C. M. A., Dolleman-Van der Weel M. J., Kitai S. T. and Lopes Da Silva F. H. (1992) Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens studied in vitro. J. Neurophysiol. 67, 1325-1334.
38. Rayport S. and Sulzer D. (1995) Visualization of antipsychotic binding to living mesolimbic neurons reveals D2 receptor mediated, acidotropic and lipophilic components. J. Neurochem. 65, 691-703.
39. Rayport S., Sulzer D., Shi W.-X., Sawasdikosol S., Monaco J., Batson D. and Rajendran G. (1992) Identified postnatal mesolimbic dopamine neurons in cell culture: Morphology and electrophysiology. J. Neurosci. 12, 4264-4280.
40. Schmalzing G. (1988) The role of a transmembrane pH gradient in uptake and release of imipramine and haloperidol in synaptosomes. Molec. Pharmac. 34, 888-895.
41. Sesack S. R., Aoki C. and Pickel V. M. (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14, 88-106.
42. Shetreat M. E., Lin L., Wong A. C. and Rayport S. (1996) Visualization of D1 dopamine receptors on living nucleus accumbens neurons and their Colocalization with D2 receptors. J. Neurochem. 66, 1475-1482.
43. Shi W.-X. and Rayport S. (1994) GABA synapses formed in vitro by local axon collaterals of nucleus accumbens neurons. J. Neurosci. 14, 4548-4560.
44. Smith A. D. and Bolam J. P. (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 13, 259-265.
45. Smith A. D., Olson R. J. and Justice J. B. Jr (1992) Quantitative microdialysis of dopamine in the striatum: Effect of circadian variation. J. Neurosci. Meth. 44, 33-41.
46. A receptors in the cerebellum of rat, cat, and monkey using monoclonal antibodies. J. Neurosci. 9, 2197-2209.
47. Surmeier D. J., Eberwine J., Wilson C. J., Cao Y., Stefani A. and Kitai S. T. (1992) Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc. Natn. Acad. Sci. U.S.A. 89, 10,178-10,182.
48. Surmeier D. J., Reiner A., Levine M. S. and Ariano M. A. (1993) Are neostriatal dopamine receptors co-localized? Trends Neurosci. 16, 299-305.
49. Surmeier D. J., Song W.-J. and Yan Z. (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16, 6579-6591.
50. Weiner D. M., Levey A. I., Sunahara R. K., Niznik H. B., O'Dowd B. F., Seeman P. and Brann M. R. (1991) D1 and D2 dopamine receptor mRNA in rat brain. Proc. Natn. Acad Sci. U.S.A. 88, 1859-1863.
51. Yung K. K. L., Bolam J. P., Smith A. D., Hersch S. M., Ciliax B. J. and Levey A. I. (1995) Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy. Neuroscience 65, 709-730.